SMS PHARMACEUTICALS LTD.

NSE : SMSPHARMABSE : 532815ISIN CODE : INE812G01025Industry : Pharmaceuticals & DrugsHouse : Private
BSE208.656.15 (+3.04 %)
PREV CLOSE ( ) 202.50
OPEN PRICE ( ) 209.85
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 91213
TODAY'S LOW / HIGH ( )201.60 211.90
52 WK LOW / HIGH ( )65 217.6
NSE209.106.5 (+3.21 %)
PREV CLOSE( ) 202.60
OPEN PRICE ( ) 202.60
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 209.10 (6000)
VOLUME 556805
TODAY'S LOW / HIGH( ) 201.30 211.50
52 WK LOW / HIGH ( )71.25 218
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax53.49684.99911.20507.56623.54
Adjustment529.90498.56277.58286.56268.07
Changes In working Capital-312.89-583.75-123.78-275.97-260.22
Cash Flow after changes in Working Capital270.50599.801065.00518.16631.38
Cash Flow from Operating Activities224.50450.60904.53397.12497.57
Cash Flow from Investing Activities-296.86-271.53-1515.92-425.64-346.73
Cash Flow from Financing Activities-319.69-117.47920.18-24.02-129.17
Net Cash Inflow / Outflow-392.0561.60308.79-52.5421.67
Opening Cash & Cash Equivalents465.83404.2395.44147.98126.31
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent73.78465.83404.2395.44147.98

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.